Investing  in  frontier technologies that elevate mental health and wellness.

INVESTMENT FOCUS

Psychedelics & New Compounds

Neurotech & BCI

Precision Psychiatry

Digital Health

Alternative Modalities

Asset-72

PURPOSE

We are a community-focused fund & syndicate that provides  capital and support  to the best and most innovative companies that align healing, responsibility, and profitability.  We can end mental illnesses.

 

INVESTMENT FOCUS

We invest in new categories that will revolutionize how mental health is treated.

PNC

PSYCHEDELIC MEDICINE
& NEW COMPOUNDS

 Psychedelics (i.e. psilocybin, MDMA, DMT, ketamine) or novel compounds to treat conditions including depression, addiction, PTSD, and more.

Asset-65

NEUROTECH &
HUMAN AUGMENTATION

Direction connection of technical components with the brain and nervous system are addressing mental health disorders and neurological diseases

Asset-64

PRECISION PSYCHIATRY

Paradigm of clinical care shifting from general approach for large populations to individual-based deep knowledge of clinical and biological characteristics

Asset-69

DIGITAL THERAPEUTICS

Software applications that help patients treat, prevent, or manage a disease, and have a proven clinical benefit

Untitled-design-5

HOLISTIC MEDICINE

Interconnection of biology, psychology, environment, and lifestyle, aiming to address root causes and promote overall well-being

Untitled-design-2

METABOLIC PSYCHIATRY

Bidirectional relationship between metabolic processes and mental health, through diet, exercise, and gut microbiota can impact brain function and psychiatric disorders.

Untitled-design-3

DIGITAL HEALTH

 Mobile applications, wearables, and online platforms that enable remote access to mental health services, and facilitate data-driven personalized care

2-1

ARTIFICIAL INTELLIGENCE

 Advanced algorithms and machine learning  to analyze vast data to enable early detection, accurate diagnosis, drug development and personalized treatment

INVESTMENTS

 

STEALTH-NEUROTECH-205-×-142-px-3

STEALTH NEUROTECH

Non-invasive treatment for mental health

STEALTH-NEUROTECH-205-×-142-px-5

STEALTH MARKETPLACE

Marketplace for transformational mental health modalities

STEALTH-NEUROTECH-205-×-142-px-3

STEALTH NEUROTECH

Transcranial-electric stimulation for mental health

2

STEALTH ARTIFICIAL INTELLIGENCE

AI-assisted therapy tool for therapists

We're donating 4.19% of our profit to psychedelic non-profits and indigenous communities since we are standing on the shoulders of giants.

PEOPLE

gradient-psymed-greg-1-1

Greg Kubin

Greg is a community builder, investor, founder. He is a co-host of Business Trip, a podcast about psychedelic entrepreneurship. Over 15 investments in psychedelic medicine  and mental health companies. Co-founded HelloSponsor, a SaaS sponsorship platform (AngelPad '15). Ex-Morgan Stanley, Viacom.

gradient-psymed-mat-2-1

Matias Serebrinsky

Matias is an investor, founder, operator and startup ecosystem builder. He previously led NVIDIA Inception North America, a startup accelerator for AI companies. Before that, he co-founded CookUnity, raising $23m from Collaborative Fund, IDC Ventures, and others. Matias is the co-host of Business Trip.

gradient-psymed-dina-2

Dina Burkitbayeva

Dina was one of the first investors in psychedelic therapeutics space and
is on the founding team of the largest psychedelic research center. Dina is also a serial entrepreneur, angel investor (Coinbase, Boom Supersonic, Mattermost), ex-McKinsey / J.P. Morgan, MBA Harvard Business School and MS in Psychology at CIIS.

gradient-psymed-caitlin-1

Caitlin Ner

Caitlin is a chief of staff, community builder, and operator. She previously executed growth and operations at Cerebral and alternative investing and asset management at BlackRock. 9 years of mental health event management and project development. Caitlin is ex-Harvard in Economics and Computer Science. 

LINKEDIN  |  TWITTER  

Asset-78

Building a company that’s elevating mental health and wellness or looking to get involved as an investor?

SEND US AN EMAIL

PsyMed-Logo-Final

©2022 PSYMED VENTURES. ALL RIGHTS RESERVED.